Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.

SOX9 Monoclonal Antibody

SOX9 Monoclonal Antibody

CAT#: NSC-P024

Inquiry

Overview Specification

Target	SOX9
Cell Type	NSCs
Host	Mouse
Isotype	IgG1
Applications	WB, IF, FC, ELISA
Reactivity	Human, mouse, canine, rabbits, rat
Conjugate	Unconjugated
Keywords	NSCs; Mouse; IgG1; WB, IF, FC, ELISA

Product Information	It targets SOX9 in WB, IF, FC, ELISA applications and shows reactivity with Human, mouse samples.
Background Information	SOX9, also named as Transcription factor SOX-9, is a 509 amino acid protein. Sex-determining region Y (SRY)-box 9 protein (SOX9) is a member of the SOX family of transcription factors (TFs) which are developmental regulators that possess high mobility group (HMG) box DNA binding and transactivation domains. It participates in a variety of functions, such as lineage restriction and terminal diferentiation, through precise temporal and spatial expression patterns that difer between particular cell types and tissues. SOX9 gene has been implicated in different types of cancer as an oncogene; however, it also may behave as a tumor suppressor.
Synonyms	CMD1, CMPD1, SOX9, SRA1, Transcription factor SOX 9
Full Name	SRY (sex determining region Y)-box 9
Tested Reactivity	Human, mouse
Cited Reactivity	Human, mouse, rat, canine, rabbits
Class	Monoclonal
Type	Antibody
Immunogen	SOX9 fusion protein
Calculated Molecular Weight	509 aa, 56 kDa
Observed Molecular Weight	56 kDa
Gene ID	6662
GenBank Accession Number	BC007951
Gene Symbol	SOX9
Form	Liquid
Purification Method	Protein A purification
Storage Buffer	PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage Conditions	Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20°C storage.
Positive WB Detected	Human placenta tissue, Caco-2 cells, HT-29 cells, NCCIT cells

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Online Inquiry

Alfa Cytology provides its clients with one-stop solutions to accelerate therapeutic discovery and development of brain tumors.

By Disease

Craniopharyngioma

Schwannoma (neuroma)

Pituitary Tumors

Choroid Plexus Tumors

By Molecule Type

Small Molecule Drug

Therapeutic Antibody

Immune Cell Therapy

Oncolytic Virotherapy

Vaccine Development

Contact Us

Copyright © 2024 Alfa Cytology. All rights reserved.